in this issue
Regions :: North America :: U.S.
Noven Completes Purchase of JDS Pharma
August 29, 2007 | DR
Noven Pharmaceuticals (Miami) says it has completed the previously announced acquisition of specialty pharma company JDS Pharmaceuticals (New York) for $125 million. The acquisition was first announced last July. JDS develops and markets branded medicines for depression and bipolar disorders. It says it also is developing high-potential drugs in the psychiatry and women’s health segments. Noven specializes in transdermal drug delivery technologies and prescription transdermal products. JDS will significantly increase Noven’s growth, and sales and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee